Cargando…
Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer
Pancreatic cancer, one of the most lethal human malignancies with dismal prognosis, is refractory to existing radio-chemotherapeutic treatment modalities. There is a critical unmet need to develop effective approaches, especially for targeted pancreatic cancer drug delivery. Targeted and drug-loaded...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955056/ https://www.ncbi.nlm.nih.gov/pubmed/27446491 http://dx.doi.org/10.7150/thno.15164 |
_version_ | 1782443883587698688 |
---|---|
author | Xing, Lingxi Shi, Qiusheng Zheng, Kailiang Shen, Ming Ma, Jing Li, Fan Liu, Yang Lin, Lizhou Tu, Wenzhi Duan, Yourong Du, Lianfang |
author_facet | Xing, Lingxi Shi, Qiusheng Zheng, Kailiang Shen, Ming Ma, Jing Li, Fan Liu, Yang Lin, Lizhou Tu, Wenzhi Duan, Yourong Du, Lianfang |
author_sort | Xing, Lingxi |
collection | PubMed |
description | Pancreatic cancer, one of the most lethal human malignancies with dismal prognosis, is refractory to existing radio-chemotherapeutic treatment modalities. There is a critical unmet need to develop effective approaches, especially for targeted pancreatic cancer drug delivery. Targeted and drug-loaded nanoparticles (NPs) combined with ultrasound-mediated microbubble destruction (UMMD) have been shown to significantly increase the cellular uptake in vitro and drug retention in vivo, suggesting a promising strategy for cancer therapy. In this study, we synthesized pancreatic cancer-targeting organic NPs that were modified with anti CA19-9 antibody and encapsulated paclitaxol (PTX). The three-block copolymer methoxy polyethylene glycol-polylacticco-glycolic acid-polylysine (mPEG-PLGA-PLL) constituted the skeleton of the NPs. We speculated that the PTX-NPs-anti CA19-9 would circulate long-term in vivo, "actively target" pancreatic cancer cells, and sustainably release the loaded PTX while UMMD would "passively target" the irradiated tumor and effectively increase the permeability of cell membrane and capillary gaps. Our results demonstrated that the combination of PTX-NPs-anti CA19-9 with UMMD achieved a low IC50, significant cell cycle arrest, and cell apoptosis in vitro. In mouse pancreatic tumor xenografts, the combined application of PTX-NP-anti CA19-9 NPs with UMMD attained the highest tumor inhibition rate, promoted the pharmacokinetic profile by increasing AUC, t(1/2), and mean residence time (MRT), and decreased clearance. Consequently, the survival of the tumor-bearing nude mice was prolonged without obvious toxicity. The dynamic change in cellular uptake, targeted real-time imaging, and the concentration of PTX in the plasma and tumor were all closely associated with the treatment efficacy both in vitro and in vivo. Our study suggests that PTX-NP-anti CA19-9 NPs combined with UMMD is a promising strategy for the treatment of pancreatic cancer. |
format | Online Article Text |
id | pubmed-4955056 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-49550562016-07-21 Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer Xing, Lingxi Shi, Qiusheng Zheng, Kailiang Shen, Ming Ma, Jing Li, Fan Liu, Yang Lin, Lizhou Tu, Wenzhi Duan, Yourong Du, Lianfang Theranostics Research Paper Pancreatic cancer, one of the most lethal human malignancies with dismal prognosis, is refractory to existing radio-chemotherapeutic treatment modalities. There is a critical unmet need to develop effective approaches, especially for targeted pancreatic cancer drug delivery. Targeted and drug-loaded nanoparticles (NPs) combined with ultrasound-mediated microbubble destruction (UMMD) have been shown to significantly increase the cellular uptake in vitro and drug retention in vivo, suggesting a promising strategy for cancer therapy. In this study, we synthesized pancreatic cancer-targeting organic NPs that were modified with anti CA19-9 antibody and encapsulated paclitaxol (PTX). The three-block copolymer methoxy polyethylene glycol-polylacticco-glycolic acid-polylysine (mPEG-PLGA-PLL) constituted the skeleton of the NPs. We speculated that the PTX-NPs-anti CA19-9 would circulate long-term in vivo, "actively target" pancreatic cancer cells, and sustainably release the loaded PTX while UMMD would "passively target" the irradiated tumor and effectively increase the permeability of cell membrane and capillary gaps. Our results demonstrated that the combination of PTX-NPs-anti CA19-9 with UMMD achieved a low IC50, significant cell cycle arrest, and cell apoptosis in vitro. In mouse pancreatic tumor xenografts, the combined application of PTX-NP-anti CA19-9 NPs with UMMD attained the highest tumor inhibition rate, promoted the pharmacokinetic profile by increasing AUC, t(1/2), and mean residence time (MRT), and decreased clearance. Consequently, the survival of the tumor-bearing nude mice was prolonged without obvious toxicity. The dynamic change in cellular uptake, targeted real-time imaging, and the concentration of PTX in the plasma and tumor were all closely associated with the treatment efficacy both in vitro and in vivo. Our study suggests that PTX-NP-anti CA19-9 NPs combined with UMMD is a promising strategy for the treatment of pancreatic cancer. Ivyspring International Publisher 2016-06-18 /pmc/articles/PMC4955056/ /pubmed/27446491 http://dx.doi.org/10.7150/thno.15164 Text en © Ivyspring International Publisher. Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. See http://ivyspring.com/terms for terms and conditions. |
spellingShingle | Research Paper Xing, Lingxi Shi, Qiusheng Zheng, Kailiang Shen, Ming Ma, Jing Li, Fan Liu, Yang Lin, Lizhou Tu, Wenzhi Duan, Yourong Du, Lianfang Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer |
title | Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer |
title_full | Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer |
title_fullStr | Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer |
title_full_unstemmed | Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer |
title_short | Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer |
title_sort | ultrasound-mediated microbubble destruction (ummd) facilitates the delivery of ca19-9 targeted and paclitaxel loaded mpeg-plga-pll nanoparticles in pancreatic cancer |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955056/ https://www.ncbi.nlm.nih.gov/pubmed/27446491 http://dx.doi.org/10.7150/thno.15164 |
work_keys_str_mv | AT xinglingxi ultrasoundmediatedmicrobubbledestructionummdfacilitatesthedeliveryofca199targetedandpaclitaxelloadedmpegplgapllnanoparticlesinpancreaticcancer AT shiqiusheng ultrasoundmediatedmicrobubbledestructionummdfacilitatesthedeliveryofca199targetedandpaclitaxelloadedmpegplgapllnanoparticlesinpancreaticcancer AT zhengkailiang ultrasoundmediatedmicrobubbledestructionummdfacilitatesthedeliveryofca199targetedandpaclitaxelloadedmpegplgapllnanoparticlesinpancreaticcancer AT shenming ultrasoundmediatedmicrobubbledestructionummdfacilitatesthedeliveryofca199targetedandpaclitaxelloadedmpegplgapllnanoparticlesinpancreaticcancer AT majing ultrasoundmediatedmicrobubbledestructionummdfacilitatesthedeliveryofca199targetedandpaclitaxelloadedmpegplgapllnanoparticlesinpancreaticcancer AT lifan ultrasoundmediatedmicrobubbledestructionummdfacilitatesthedeliveryofca199targetedandpaclitaxelloadedmpegplgapllnanoparticlesinpancreaticcancer AT liuyang ultrasoundmediatedmicrobubbledestructionummdfacilitatesthedeliveryofca199targetedandpaclitaxelloadedmpegplgapllnanoparticlesinpancreaticcancer AT linlizhou ultrasoundmediatedmicrobubbledestructionummdfacilitatesthedeliveryofca199targetedandpaclitaxelloadedmpegplgapllnanoparticlesinpancreaticcancer AT tuwenzhi ultrasoundmediatedmicrobubbledestructionummdfacilitatesthedeliveryofca199targetedandpaclitaxelloadedmpegplgapllnanoparticlesinpancreaticcancer AT duanyourong ultrasoundmediatedmicrobubbledestructionummdfacilitatesthedeliveryofca199targetedandpaclitaxelloadedmpegplgapllnanoparticlesinpancreaticcancer AT dulianfang ultrasoundmediatedmicrobubbledestructionummdfacilitatesthedeliveryofca199targetedandpaclitaxelloadedmpegplgapllnanoparticlesinpancreaticcancer |